Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs maintains a Buy rating

06/01/2021 | 03:37pm EDT

In a research note published by Veronika Dubajova, Goldman Sachs advises its customers to buy the stock. The target price is set at 70 versus 69 EUR.


ę MarketScreener with dpa-AFX Analyser 2021
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
02:27aFMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Sell rating from Jefferies
MD
08/04DGAP-DD : Fresenius SE & Co. KGaA english
DJ
08/04FMC FRESENIUS MEDICAL CARE AG & CO K : NorldLB maintains a Buy rating
MD
08/04FRESENIUS MEDICAL CARE : uses virtual reality technology to train patients for h..
PU
08/03European ADRs Move Higher in Tuesday Trading
MT
08/02European ADRs Move Higher in Monday Trading
MT
08/02FRESENIUS MEDICAL CARE : RBC Raises Price Target on Fresenius Medical Care to $4..
MT
08/02FRESENIUS : Lifts FY21 Group Earnings Outlook After 'Very Strong' H1
MT
07/30ADRs End Lower; IAG, Fresenius Among Companies Actively Trading
DJ
07/30DGAP-CMS : Fresenius Medical Care AG & Co. KGaA: Release according to Article 50..
DJ
More news
Financials (USD)
Sales 2021 21 228 M - -
Net income 2021 1 246 M - -
Net Debt 2021 13 335 M - -
P/E ratio 2021 18,7x
Yield 2021 1,74%
Capitalization 23 416 M 23 413 M -
EV / Sales 2021 1,73x
EV / Sales 2022 1,62x
Nbr of Employees 123 538
Free-Float 67,8%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | FME | DE0005785802 | MarketScreener
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Last Close Price 79,92 $
Average target price 83,05 $
Spread / Average Target 3,91%
EPS Revisions
Managers and Directors
Rice Powell Chief Executive Officer
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer